Spire Healthcare Group plc (LON:SPI - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 259.50 ($3.26) and last traded at GBX 258.80 ($3.25), with a volume of 163143 shares. The stock had previously closed at GBX 253.50 ($3.18).
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on the stock. Berenberg Bank lifted their price objective on shares of Spire Healthcare Group from GBX 286 ($3.59) to GBX 300 ($3.77) and gave the company a "buy" rating in a report on Wednesday, April 17th. JPMorgan Chase & Co. reiterated an "overweight" rating and set a GBX 344 ($4.32) price target on shares of Spire Healthcare Group in a research note on Thursday, April 18th.
Check Out Our Latest Report on Spire Healthcare Group
Spire Healthcare Group Price Performance
The stock has a market cap of £1.05 billion, a P/E ratio of 3,648.74, a price-to-earnings-growth ratio of 1.06 and a beta of 0.97. The company has a quick ratio of 0.74, a current ratio of 0.69 and a debt-to-equity ratio of 170.37. The business's 50-day simple moving average is GBX 241.58 and its two-hundred day simple moving average is GBX 233.17.
Spire Healthcare Group Increases Dividend
The business also recently disclosed a dividend, which will be paid on Friday, June 21st. Investors of record on Thursday, May 23rd will be issued a dividend of GBX 2.10 ($0.03) per share. This is a boost from Spire Healthcare Group's previous dividend of $0.50. The ex-dividend date of this dividend is Thursday, May 23rd. This represents a yield of 0.89%. Spire Healthcare Group's dividend payout ratio is 4,285.71%.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Further Reading
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
